News

FRIDAY, April 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine. The decision had been expected by April 1 ...
WEDNESDAY, April 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration’s (FDA) top tobacco regulator, Brian King, has been placed on leave as part of a large wave of cuts across ...
The justices threw out a lower court's decision that the FDA had failed to follow proper legal procedures under a federal law called the Administrative Procedure Act when it rejected the ...
Dozens of other employees in FDA’s tobacco center also received notices Tuesday morning that they were being dismissed, including two entire offices responsible for drafting new tobacco ...
This comes as it was announced last week that a further 3,500 jobs at the FDA would be cut, with some existing review staff now with double the workload due to previous personnel losses.
Supply issues finally started to ease late in 2024, as compounded semaglutide — "copycats" of the patented stuff like Ozempic and Zepbound — began to flood the market when the FDA temporarily ...
Hilary Perkins spent all of two days working in the second Trump administration before becoming used as a confirmation pawn to secure the path forward for President Donald Trump’s nominee for ...
Dr. Peter Marks sent a letter to Acting FDA Commissioner Sara Brenner on Friday saying that he would resign and retire by April 5 as director of the Center for Biologics Evaluation and Research.
Dr. Peter Marks sent a letter to acting FDA Commissioner Sara Brenner on Friday saying that he would resign and retire by April 5 as director of the Center for Biologics Evaluation and Research.
Greg Nash/The Hill/Bloomberg via Getty; Kevin Dietsch/Getty Dr. Peter Marks, one of the U.S. Food and Drug Administration’s (FDA) top vaccine officials, has resigned. In a resignation letter ...
A top vaccine official at the Food and Drug Administration (FDA) resigned, citing Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s “misinformation” and apparent lack of ...